Paula Ragan is CEO & President at X4 Pharmaceuticals, Inc (XFOR). They have made 5 open-market trades across 1 company since 2020, most recently 2025-02-12.
CIK 0001769914
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XFOR | 3,337,386 | $8.6M |
Shares reported on the most recent Form 4, priced at the 2025-02-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XFOR | SELL · 10b5-1 | 2025-01-24 | 2025-01-27 | $0.45 | $34K | +12.2% | -17.0% | -63.7% |
| XFOR | SELL · 10b5-1 | 2024-11-15 | 2024-11-19 | $0.39 | $12K | +1.6% | +66.4% | +36.6% |
| XFOR | SELL · 10b5-1 | 2024-10-15 | 2024-10-16 | $0.56 | $18K | -6.9% | -24.8% | -15.1% |
| XFOR | SELL | 2024-10-07 | 2024-10-08 | $0.55 | $263K | -5.5% | +12.1% | +34.5% |
| XFOR | SELL · 10b5-1 | 2024-03-11 | 2024-03-11 | $0.88 | $44K | +44.0% | +34.1% | +14.3% |
| XFOR | SELL · 10b5-1 | 2024-02-12 | 2024-02-12 | $1.01 | $22K | -5.3% | -15.0% | -1.3% |
| XFOR | SELL · 10b5-1 | 2023-11-01 | 2023-11-03 | $0.75 | $327K | -12.7% | -8.7% | -6.7% |
| XFOR | SELL · 10b5-1 | 2023-06-23 | 2023-06-26 | $1.92 | $13K | +4.3% | -3.8% | -43.2% |
| XFOR | SELL · 10b5-1 | 2023-06-15 | 2023-06-16 | $2.23 | $15K | -12.3% | -15.2% | -42.7% |
| XFOR | SELL · 10b5-1 | 2023-05-31 | 2023-05-31 | $1.95 | $12K | +12.4% | -4.0% | -35.1% |
| XFOR | SELL · 10b5-1 | 2023-03-10 | 2023-03-13 | $0.84 | $42K | -8.7% | +23.9% | +146.7% |
| XFOR | SELL · 10b5-1 | 2023-02-13 | 2023-02-15 | $0.93 | $20K | -5.3% | -15.2% | +77.8% |
| XFOR | SELL · 10b5-1 | 2022-06-03 | 2022-06-06 | $1.21 | $8K | -7.8% | -6.0% | -2.6% |
| XFOR | SELL | 2021-08-17 | 2021-08-19 | $5.10 | $137K | +14.0% | +13.8% | +6.7% |
| XFOR | SELL | 2021-07-15 | 2021-07-16 | $5.78 | $155K | +4.9% | -0.5% | -4.2% |
| XFOR | SELL · 10b5-1 | 2021-06-02 | 2021-06-02 | $9.50 | $23K | -11.0% | -34.4% | -45.6% |
| XFOR | SELL · 10b5-1 | 2021-06-01 | 2021-06-02 | $9.41 | $39K | -11.0% | -34.4% | -45.6% |
| XFOR | SELL · 10b5-1 | 2021-05-03 | 2021-05-04 | $8.33 | $20K | -9.1% | +10.3% | -29.3% |
| XFOR | SELL · 10b5-1 | 2021-04-05 | 2021-04-07 | $9.17 | $22K | +1.1% | -12.5% | -33.4% |
| XFOR | SELL · 10b5-1 | 2021-03-02 | 2021-03-02 | $9.74 | $23K | -2.6% | -7.9% | -3.1% |
| XFOR | SELL · 10b5-1 | 2021-02-02 | 2021-02-03 | $7.88 | $19K | +11.2% | +20.4% | +6.0% |
| XFOR | SELL · 10b5-1 | 2021-01-05 | 2021-01-06 | $7.00 | $17K | +24.7% | +22.7% | +31.3% |
| XFOR | SELL · 10b5-1 | 2020-12-23 | 2020-12-28 | $7.00 | $34K | +21.8% | +12.5% | +28.4% |
| XFOR | SELL · 10b5-1 | 2020-10-05 | 2020-10-06 | $7.00 | $13K | -3.6% | -13.9% | -5.0% |
| XFOR | SELL · 10b5-1 | 2020-10-02 | 2020-10-05 | $7.00 | $4K | -15.7% | -13.3% | -10.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.